|
||
![]() |
Home >> About Us >> Management Team Management Team
Luis DeTaboada, VP of Research and Development Thomas J. McCarthy, D.V.M., VP of Clinical Marketing/Business Development Steven P. Richieri, Senior VP of Operations Amy Walters, Consulting Regulatory Executive Thomas C. Wilder III Mr. Wilder served most recently as President of ev3's Neurovascular Division. From 2002 to 2006, he served as President and Chief Executive Officer of MicroTherapeutics Inc., a publicly-held medical device company focused on neurovascular technologies. MicroTherapeutics, Inc. was acquired by ev3 in January 2006.
From 1991 to 2002, Mr. Wilder served at Medtronic Inc., most recently as Vice President and General Manager of its endovascular stent grafts division. During his tenure at Medtronic, he also held a variety of positions at
Dr. Streeter founded PhotoThera after evaluating therapeutic infrared laser technology for the U.S. Navy in the mid 90’s. He is one of the pioneering scientists in the area of using infrared energy for the treatment of injured tissue and is the holder of numerous issued and pending patents utilizing the technology. Dr. Streeter serves on the Board of Directors and is also the co-chairman of the medical device committee of BIOCOM.
Dr. Streeter earned his B.S. degree in Biology, graduating with High Distinction from the
Vice-President of Manufacturing Mr. Anthony joined PhotoThera in January of 2008 as the Vice-President of Manufacturing. His most recent experience is from Abbot Vascular/Guidant Corporation, where he was Director of Operations for the Endovascular Solutions (ES) Business Unit. Mr. Anthony established the entire supply chain infrastructure for the ES Business Unit and was part of the management team responsible for the successful launch of the first carotid stent and embolic protection system approved in the U.S. Mr. Anthony was also part of the management at Origin Medsystems prior to its acquisition by Eli Lilly & Company and Eli Lilly's formation of Guidant. Mr. Anthony brings to PhotoThera over 20 years of in-depth manufacturing operations experience. He received a B.S. in Business Administration from Saint Mary's College of California and a MBA from Santa Clara University. Vice-President of Quality Assurance Mr. Carner joined PhotoThera in January of 2008 as the Vice-President of Quality Assurance. His most recent experience is from Abbott Vascular/Guidant Corporation, where he was Director of Quality Systems responsible for global Quality System integration activities with Abbott Vascular. While at Guidant Corporation, Mr. Carner was also part of the management team responsible for the successful launch of the first carotid stent and embolic protection system approved in the Luis DeTaboada Mr. De Taboada joined PhotoThera in 2001 as Vice-President of Research and Development. He was responsible for the design, development, and preclinical testing of the devices including those used during PhotoThera’s NEST-1 and NEST-2 trials. Prior to working at PhotoThera, Mr. De Taboada worked as Director of New Product Development at Laser Mechanisms, establishing and managing West Coast operations. Previously, he was Engineering Manager at Medical Optics, a division of Kaiser Aerospace and Electronics where he led the development of novel Carbon Dioxide lasers, laser systems, fiber beam delivery systems, and research in head mounted displays for minimally invasive surgery. Mr. DeTaboada holds an M.S. in Electrical Engineering and a B.S. in Applied Mathematics from the
Dr. Ilic joined PhotoThera in 2003 as Vice-President of Clinical and Regulatory Affairs. She has held executive positions both in the academic environment and pharma/biotech industry at Johnson & Johnson (WW Director, Clinical Research, Codman), Medtronic MiniMed (Director Clinical Research), Sansum Medical Research Institute (Senior Scientist), and Thomas J. McCarthy, D.V.M. Prior to joining PhotoThera in 2007, Dr. McCarthy was a Director of Business Development for ev3, Inc. From 2002-2006 he was Director, Clinical Marketing and Business Development for MicroTherapeutics, Inc., an interventional neuroradiology company. Dr. McCarthy previously held management positions in Business Development, Marketing, R&D and Veterinary Resources at Edwards Lifesciences, Baxter Healthcare and the Washington University School of Medicine. He also completed a Post-Doctoral Research Fellowship at the University of Illinois Medical School. Dr. McCarthy holds D.V.M. and B.S. degrees from the Steven P. Richieri Mr. Richieri served as SVP/Head of Operations for Egea Biosciences from 2002 to 2005 and was a key member of the executive team responsible for the sale of Egea to the Johnson and Johnson Corporation in May, 2004. From 1999 to 2002, Mr. Richieri was a co-founder and served as President and CEO of NuVista Technology Corporation, a privately-held medical device company. During that time, he also a co-founded ALSP, a privately held drug discovery company. Prior to NuVista and ALSP, Mr. Richieri served as Chief Operating Officer for The Immune Response Corporation, a publicly-traded biotechnology company, where he was responsible for all corporate operations and product development activities between 1991 and 1999. From 1983 to 1991, Mr. Richieri was VP of Regulatory and Technical Affairs at Dura Pharmaceuticals. Mr. Richieri received a B.S. in Pharmacy from Rutgers College of Pharmacy and a M.B.A. from the
Dr. Sorich joined PhotoThera in July of 2006 as Vice-President of Engineering. He brings over two decades of broad medical device experience, including experience at start-ups and larger companies (e.g., Medtronic, American Hospital Supply, Boehringer Mannhein). Rick has a Ph.D. in Biomedical Engineering from UC Santa Barbara, and M.S. and B.S. degrees in Computer Science & Electrical Engineering from UC Berkeley. Consulting Regulatory Executive |
|
|
||
| Information Disclaimer | ||